MI Bioresearch (MI) was one of the first CROs to offer imaging-based preclinical in vivo biodistribution studies. We offer the industry’s widest range of small animal imaging modalities for your studies, including:
Our systems provide the best solution to quantify biodistribution, kinetics, and targeting of your therapy in rodents.
From immuno-PET for antibody drugs, to tracking of cell therapies and nanoparticles using MRI, to looking at how your gene delivery technology behaves using BLI, and to seeing how your tumor-targeting nanoparticle is working by fluorescence molecular tomography (FMT), we have the right tools at your disposal.
Imagine your biologic distributing, targeting, and clearing … in vivo